Einar M. Sigurdsson
- Neurology top 0.2%
- Neuroinflammation and Neurodegeneration Mechanisms 44
- Physiology top 0.2%
- Alzheimer's disease research and treatments 100
- Biological Psychiatry top 1%
- Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases 20
-
- Neuroscience and Neuropharmacology Research 34
-
- Prion Diseases and Protein Misfolding 20
-
- Computational Drug Discovery Methods 12
-
- Trace Elements in Health 8
-
- Cellular transport and secretion 5
- Co-authors
- Erin E. CongdonThomas WısnıewskıBlas FrangioneDavid QuartermainAllal BoutajangoutClaudio SotoAyodeji A. AsuniHenrieta Scholtzova
- Journals
- Journal of Biological Chemistry (4 papers)Nature Medicine (1 paper)Journal of Neuroscience (4 papers)
- Partner nations
- United StatesFranceDenmark
In The Last Decade
Einar M. Sigurdsson
116 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Neurology 2.1k
- Physiology 5.1k
- Biological Psychiatry 378
- Pharmacology 1.5k
- Cellular and Molecular Neuroscience 1.4k
Countries citing papers authored by Einar M. Sigurdsson
This map shows the geographic impact of Einar M. Sigurdsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einar M. Sigurdsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einar M. Sigurdsson more than expected).
Fields of papers citing papers by Einar M. Sigurdsson
This network shows the impact of papers produced by Einar M. Sigurdsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einar M. Sigurdsson. The network helps show where Einar M. Sigurdsson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Einar M. Sigurdsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 14 | |
| 3 | 2022 | 18 | |
| 4 | 2020 | 13 | |
| 5 | 2018 | 23 | |
| 6 | 2018 | 6 | |
| 7 | 2018 | 3 | |
| 8 | 2014 | 48 | |
| 9 | 2013 | 159 | |
| 10 | 2010 | 61 | |
| 11 | 2010 | 1 | |
| 12 | 2008 | 104 | |
| 13 | 2005 | 74 | |
| 14 | 2005 | 11 | |
| 15 | 2003 | 5 | |
| 16 | 2002 | 150 | |
| 17 | 2002 | 165 | |
| 18 | 2001 | 210 | |
| 19 | β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapybreakdown → | 1998 | 742 |
| 20 | 1996 | 43 |
About Einar M. Sigurdsson
Einar M. Sigurdsson is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience, having authored 120 papers that have together received 7.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (100 papers), Neuroinflammation and Neurodegeneration Mechanisms (44 papers), Neuroscience and Neuropharmacology Research (34 papers), Prion Diseases and Protein Misfolding (20 papers), Cholinesterase and Neurodegenerative Diseases (20 papers), Computational Drug Discovery Methods (12 papers), Trace Elements in Health (8 papers) and Cellular transport and secretion (5 papers). The work is most often cited by research in Neurology (2.1k citations), Physiology (5.1k citations) and Biological Psychiatry (378 citations). Einar M. Sigurdsson has collaborated with scholars based in United States, France and Denmark. Frequent co-authors include Erin E. Congdon, Thomas Wısnıewskı, Blas Frangione, David Quartermain, Allal Boutajangout, Claudio Soto, Ayodeji A. Asuni, Henrieta Scholtzova, Laura Morelli and Eduardo M. Castaño. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.